Cargando…
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
Immune thrombocytopenia (ITP) is an acquired bleeding autoimmune disorder characterized by a markedly decreased blood platelet count. The disorder is variable, frequently having an acute onset of limited duration in children and a more chronic course in adults. A number of therapeutic agents have de...
Autores principales: | Cheung, Eric, Liebman, Howard A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726056/ https://www.ncbi.nlm.nih.gov/pubmed/19707396 |
Ejemplares similares
-
Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies
por: Osaro, Erhabor, et al.
Publicado: (2010) -
Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping
por: Stensrud, Monica, et al.
Publicado: (2023) -
Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD(+) red blood cells to escape alloanti-RhD immunological recognition
por: Zhang, Yinze, et al.
Publicado: (2020) -
RHD genotyping to resolve weak and discrepant RhD patient phenotypes
por: Barriteau, Christina M., et al.
Publicado: (2022) -
The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals
por: Ying, Yanling, et al.
Publicado: (2021)